I agree with you on first reading. The corporate expenses have grown over the quarter. However, my gut feeling is some commercially sensitive (competitors read HC too) stuff is going on in the background in US and Canada. The commentary alludes to this without specifics. Prepared to watch closely in coming announcements. SC Performance Rights KPIs are a fairly accurate way of understanding the Boards thinking to some of the above. I am reading the tea-leaves a bit but hopefully good news coming from this Corporate expenditure in Q1.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $10.60M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $25.85K | 173.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9024 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 13699 | 3 |
View Market Depth
| Last trade - 15.49pm 29/07/2025 (20 minute delay) ? |
| SPA (ASX) Chart |